• FPH1 (BRD-6125): Enabling Functional Hepatocyte Expansion fo

  2026-06-21

  Explore how FPH1 (BRD-6125) advances primary human hepatocyte expansion, with an in-depth look at its synergy with optogenetic gene regulation and translational research. Uncover unique mechanistic insights and evidence-based protocols for functional proliferation assays.

• Tacalcitol Monohydrate: Precision Modulation of Keratinocyte

  2026-06-20

  Explore the multi-dimensional effects of Tacalcitol monohydrate, a synthetic analog of vitamin D3, on keratinocyte biology and cancer research. This article uniquely dissects its NGF induction kinetics, practical assay implications, and translational relevance beyond prior reviews.

• Guanabenz Acetate: Decoding α2-Adrenergic Receptor Signaling

  2026-06-19

  Explore how Guanabenz Acetate, a selective α2-adrenergic receptor agonist, is enabling next-generation research on GPCR signaling and innate immunity. This article delivers a unique, in-depth analysis of its mechanistic roles and experimental implications, including novel insights from recent SARS-CoV-2 studies.

• Sulforaphane: A Mechanism-Driven Catalyst for Translational

  2026-06-19

  This thought-leadership article explores sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane) as a powerful tool for translational researchers. Through mechanistic insights, experimental validation, and strategic recommendations, it highlights how APExBIO’s sulforaphane enables advanced modeling of cancer chemoprevention and inflammatory mechanisms—particularly oxidative stress and NLRP3 inflammasome activation—while offering actionable guidance for cross-domain research and future clinical translation.

• PD 173074: Precision FGFR1/VEGFR2 Inhibition in Translationa

  2026-06-18

  PD 173074 is a highly selective FGFR1/VEGFR2 inhibitor with nanomolar potency, serving as a gold-standard tool for dissecting FGFR signaling in cancer and neuroscience. This article offers mechanistic insights and strategic considerations for translational researchers, contrasting PD 173074’s profile with pan-FGFR inhibitors and navigating its optimal application in experimental and preclinical workflows.

• Cell Counting Kit-8 Plus: Optimizing Tetrazolium Salt Assays

  2026-06-18

  Cell Counting Kit-8 (CCK-8) Plus elevates cell proliferation and cytotoxicity workflows with unmatched sensitivity, speed, and reliability. This guide details advanced use cases, protocol enhancements, and troubleshooting, anchored by translational research that leverages WST-8 chemistry for robust, data-driven discovery.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for Dual Fluorescence Assays

  2026-06-17

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers precise, real-time tracking of mRNA delivery and translation in complex cellular systems, including hard-to-transfect macrophages. Its dual-fluorescent design and immune-evasive modifications streamline experimental workflows, optimize quantitative transfection studies, and advance macrophage-targeted therapeutic development.

• Purmorphamine as a Smoothened Agonist: Protocols for Bone &

  2026-06-17

  Purmorphamine stands out as a potent Smoothened agonist, enabling precise modulation of Hedgehog signaling in both vertebrate and invertebrate systems. This article decodes its applied workflows, from osteogenic induction to sensory biology, and translates recent Apis mellifera advances into actionable research strategies.

• Nilotinib (AMN-107): Applied Workflows in Kinase Signaling R

  2026-06-16

  Nilotinib (AMN-107) stands out as a precision tool for dissecting BCR-ABL signaling in chronic myeloid leukemia and modeling kinase-driven tumor biology. This article translates recent mechanistic breakthroughs and best-practice protocols into actionable guidance for advanced cancer research.

• Sisomicin Aminoglycoside Antibiotic: Workflows, Applications

  2026-06-16

  Sisomicin stands out as a robust aminoglycoside antibiotic for both Gram-negative and Gram-positive infection research, offering reproducible inhibition of bacterial protein synthesis. This guide details advanced experimental workflows and troubleshooting strategies, leveraging the latest comparative evidence to maximize assay reliability in bench and translational studies.

• Sulfo-Cy5 Carboxylic Acid: Reliable Fluorescence for Life Sc

  2026-06-15

  This article provides a scenario-driven, evidence-based guide for leveraging Sulfo-Cy5 carboxylic acid (SKU A8137) in protein and peptide labeling workflows. Drawing from published data and real-world laboratory practice, it highlights how this hydrophilic, quenching-resistant fluorescent dye streamlines imaging and assay reproducibility in biomedical research.

• Tacalcitol Monohydrate Enhances 5-FU Efficacy in CRC via TS

  2026-06-15

  The reference study uncovers how tacalcitol, a synthetic analog of vitamin D3, mechanistically enhances 5-fluorouracil (5-FU) efficacy in colorectal cancer by downregulating thymidylate synthase through vitamin D receptor pathways. These findings have significant implications for the rational design of combination therapies and biomarker-driven patient stratification in colorectal cancer research.

• Selective Autophagy Regulates IRF3 Stability and IFN Respons

  2026-06-14

  Wu et al. reveal that selective macroautophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, fine-tunes the degradation of IRF3 and thus balances type I interferon production with immune suppression. This study provides mechanistic insight into transcription factor regulation in antiviral immunity and highlights new avenues for dissecting immune signaling pathways.

• NF 449: Purinergic Receptor Antagonist for Platelet Assays

  2026-06-13

  NF 449 stands out as a highly selective purinergic receptor antagonist, enabling researchers to dissect P2X1-mediated platelet activation with unprecedented precision. Its potent inhibition profile and workflow-validated reproducibility make it a cornerstone for advanced antithrombotic agent research and troubleshooting complex platelet aggregation assays.

• p-Cresyl Sulfate Drives Valve Calcification via Klotho/SIRT1

  2026-06-12

  This study reveals that p-cresyl sulfate, a key uremic toxin, accelerates calcification in aortic valvular interstitial cells by suppressing klotho and SIRT1 signaling pathways. These findings elucidate a mechanistic bridge between chronic kidney disease and calcific aortic valve disease, highlighting new targets for intervention in vascular complication studies.

408 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page